SEGLUROMET 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 7.5 mg/1 is used to help manage type 2 diabetes in adults. It works by improving blood sugar control, often alongside diet and exercise. This medication is not suitable for treating type 1 diabetes or diabetic ketoacidosis. Always consult a healthcare provider to determine if this medication is appropriate for your condition.

Common effects of Segluromet 7.5 mg/1 may include urinary tract infections, genital mycotic infections, and hypoglycemia when combined with other diabetes medications. Some users may experience gastrointestinal discomfort, such as nausea or diarrhea. These effects vary by individual and are not exhaustive.

Handle Segluromet 7.5 mg/1 with care, especially if you have kidney issues, as it may affect kidney function. Avoid alcohol while taking this medication, as it can increase the risk of lactic acidosis. Store the tablets in a cool, dry place away from direct sunlight and keep them out of reach of children.

Segluromet 7.5 mg/1 may interact with certain medications, including diuretics, ACE inhibitors, and NSAIDs. Alcohol can increase the risk of lactic acidosis, so it should be avoided. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.